Search results
Results from the WOW.Com Content Network
Cancer Immunology, Immunotherapy is a monthly peer-reviewed medical journal published by Springer Science+Business Media. According to the Journal Citation Reports , the journal has a 2020 impact factor of 6.968.
Cancer Immunology Research is a monthly peer-reviewed medical journal published by the American Association for Cancer Research. It covers research and clinical trials related to the study of cancer immunology. The editors-in-chief are Robert D. Schreiber and Philip Greenberg. [1] The journal was established in 2013. [1]
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
The journal was established in 1966 and is published by John Wiley & Sons on behalf of the Union for International Cancer Control. The editor-in-chief is Christoph Plass (Deutsches Krebsforschungszentrum). According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.396. [1]
The Journal of Cancer is a peer-reviewed open access medical journal covering all areas of cancer research and oncology, published by Ivyspring International Publisher. The editors-in-chief are Yan-Gao Man (Bon Secours Cancer Institute) and Naoto T. Ueno (University of Texas M. D. Anderson Cancer Center).
Cancers is a peer-reviewed, open access, medical journal published by MDPI covering all fields of oncology. [1] The editor-in-chief is Samuel C. Mok (The University of Texas MD Anderson Cancer Center). The Irish Association for Cancer Research (IACR) and the Signal Transduction Society (STS) are affiliated societies.
The journal obtained its current name in 1979. [2] It is published by Springer Science+Business Media under a hybrid publishing model and the editor-in-chief is Klaus Hoffken (University of Düsseldorf). According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.322.
The editors-in-chief are Vincent T. DeVita (Yale Cancer Center), Theodore S. Lawrence (University of Michigan), and Steven Rosenberg (National Cancer Institute). According to the Journal Citation Reports, the journal has a 2022 impact factor of 2.2, ranking it 199th out of 241 journals in the category "Oncology". [1]